United States · 
What does Leukemia & Lymphoma Society invest in?
Leukemia & Lymphoma Society invests most often at Series B and Venture (100% of the rounds on record).
Leukemia & Lymphoma Society highlights
- 01
2 rounds on record
- 02
Mostly Series B and Venture: 100% of its rounds
- 03
Sole investor in 2 rounds, median $7.2M
- 04
1 exits from the portfolio
What they do
- Type
- Investment firm (from a list, unverified)
- Cheque size
- Not stated
- Based in
- Washington, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2014
1 round
- Aug
- 2011
1 round
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
EpizymeListed$60MMay 2013
An exit counts when it came after the firm's first round in the company. From historical deal records.